Obliteride Funding in Action

In 2017, Obliteride raised $2.8 million for cancer research at Fred Hutch. Cures start here — because of you.
Obliteride funds research in the areas of greatest need at Fred Hutch. From Basic Sciences and Public Health to deep exploration into organ-specific cancers and immunotherapy, we've funded over $12 million in research over the past four years. The areas we've been able to impact, with the dollars you've raised and/or donated in 2017, include:

HUTCH RESEARCHERS POWERED BY 2017 OBLITERIDE

JESSE D. BLOOM, PhD

EMILY HATCH, PhD

Hatch,-E.jpg
Hatch Lab
Biology of the Nucleus
What The Hatch Lab Does
CECILIA MOENS, PhD

Moens,-C.jpg
Moens Lab
Cell Development Neurobiology
ROLAND STRONG, PhD

Strong,-R-(2).jpg
Strong Lab
Translational Biophysics, Structural Molecular Immunology and Vaccinology
New technological platform opens unexplored world of tiny proteins
JENNIFER ADAIR, PhD

Adair,-J-(1).jpg
Adair Lab
PAUL CARPENTER, MD.BS

Carpenter,-P.jpg
Lymphoma and Leukemia

 
RACHEL CEBALLOS, PhD

Ceballos,-R.jpg
Ceballos Lab
KEVIN CHEUNG, MD, PhD

Cheung,-K.jpg
Cheung Lab